Dmdiscovery Trademark Details

Dmdiscovery was registered on Tuesday, April 1, 2008 and is currently owned by Laboratory Corporation of America Holdings under the registration number 3406007 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 9 years ago on Friday, November 7, 2014, according to the United State Patent & Trademark Office
Word Mark Dmdiscovery
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Laboratory Corporation of America Holdings of Burlington, NC

View all trademarks for Laboratory Corporation of America Holdings
Other Trademarks for Laboratory Corporation of America Holdings

Previous Owners

Tandem Labs Inc. of Trenton, NJ

View all trademarks for Tandem Labs Inc.
Other Trademarks for Tandem Labs Inc.
Serial Number 77009660
Registration Number 3406007
Status Date Friday, November 7, 2014
Filing Date Friday, November 7, 2014
Registration Date Tuesday, April 1, 2008
Attorney David W. Osborne

Correspondent

DAVID W. OSBORNE
THORPE NORTH & WESTERN, LLP
PO BOX 1219
SANDY, UT 84091-1219

Case File Statements

Goods & Services Mass spectrometry-based pharmacokinetics and pharmacodynamics (PK/PD) for drug metabolite profiling, drug metabolite identification, and drug metabolite quantitation; Mass spectrometry-based pharmacokinetics and pharmacodynamics (PK/PD) for biomarker profiling
Pseudo Mark Dm Discovery

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, November 7, 2014
First Use Anywhere Monday, December 17, 2007
First Use In Commerce Monday, December 17, 2007
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.